Modeling the interactions between osteoblast and osteoclast activities in bone remodeling V Lemaire, FL Tobin, LD Greller, CR Cho, LJ Suva Journal of theoretical biology 229 (3), 293-309, 2004 | 564 | 2004 |
Mechanistic overview of immune checkpoints to support the rational design of their combinations in cancer immunotherapy A Rotte, JY Jin, V Lemaire Annals of Oncology 29 (1), 71-83, 2018 | 345 | 2018 |
Structural modeling of drug release from biodegradable porous matrices based on a combined diffusion/erosion process V Lemaire, J Belair, P Hildgen International journal of pharmaceutics 258 (1-2), 95-107, 2003 | 155 | 2003 |
Numerical bifurcation analysis of delay differential equations arising from physiological modeling K Engelborghs, V Lemaire, J Belair, D Roose Journal of mathematical biology 42, 361-385, 2001 | 115 | 2001 |
Sequential recruitment and combinatorial assembling of multiprotein complexes in transcriptional activation V Lemaire, CF Lee, J Lei, R Métivier, L Glass Physical review letters 96 (19), 198102, 2006 | 39 | 2006 |
Pharmacology-based ranking of anti-cancer drugs to guide clinical development of cancer immunotherapy combinations V Lemaire, CS Shemesh, A Rotte Journal of Experimental & Clinical Cancer Research 40 (1), 311, 2021 | 35 | 2021 |
Spatial effects in modeling pharmacokinetics of rapid action drugs P Lafrance, V Lemaire, F Varin, F Donati, J Bélair, F Nekka Bulletin of mathematical biology 64 (3), 483-500, 2002 | 11 | 2002 |
Dynamics of Bone Cell Interactions and Differential Responses to PTH and Antibody-Based Therapies V Lemaire, DR Cox Bulletin of Mathematical Biology, 1–48, 2018 | 10 | 2018 |
From cold to hot: changing perceptions and future opportunities for quantitative systems pharmacology modeling in cancer immunotherapy V Lemaire, D Bassen, M Reed, R Song, S Khalili, YT Lien, L Huang, ... Clinical Pharmacology & Therapeutics 113 (5), 963-972, 2023 | 9 | 2023 |
Bilayer Composition for the Sustained Release of Acetaminophen and Tramadol A Bichara, S Gervais, D Le Garrec, P Ouadji, V Sant, S Gosein, V Lemaire, ... US Patent App. 12/252,117, 2008 | 8* | 2008 |
Modeling and simulation to optimize efficacy and tolerability for once a day trazodone formulation V Lemaire, C Benquet, D LeGarrec, SD Robertson Sy, SM Stahl Abstract presented at: The European College of Neuropsychopharmacology meeting, 2009 | 3* | 2009 |
Sample Size Determination and Statistical Hypothesis Testing for Core Centration in Press Coated Tablets PL de Micheaux, V Lemaire Open Journal of Statistics 2 (3), 269-273, 2012 | 1 | 2012 |
No Recipe for Quantitative Systems Pharmacology Model Validation, but a Balancing Act Between Risk and Cost V Lemaire, C Hu, PH van der Graaf, S Chang, W Wang Clinical Pharmacology & Therapeutics, 2023 | | 2023 |
IDENTIFYING BIOLOGICAL SIGNALS DIFFERENTIATING RESPONDERS AND NON-RESPONDERS TO MPDL3280A (ANTI-PDL1) IN NON-SMALL CELL LUNG CANCER USING QUANTITATIVE SYSTEMS PHARMACOLOGY … V Lemaire, A Rotte, K Gadkar, JY Jin, S Ramanujan CLINICAL PHARMACOLOGY & THERAPEUTICS 105, S119-S119, 2019 | | 2019 |
Modélisation de la libération de substances bioactives et des conséquences sur la dynamique physiologique V Lemaire University of Montreal, 2003 | | 2003 |